Natural Alternatives to Ocaliva (Obeticholic Acid)

Veronica Hackethal | MD, MSc

Medically reviewed by Veronica Hackethal | MD, MSc, Harvard University | University of Oxford | Columbia Vagelos College of Physicians and Surgeons on July 27th, 2026.

Published on July 25th, 2026. Updated on July 28th, 2026.

General 6 min

Key takeaways

  • No natural supplement currently replicates the farnesoid X receptor (FXR) agonist mechanism of obeticholic acid based on current clinical evidence.

  • UDCA (ursodeoxycholic acid) is the closest evidence-backed alternative and is often the first therapy prescribed before or alongside Ocaliva for PBC.

  • TUDCA and berberine show the most relevant biological mechanisms among over-the-counter options, but robust human trial data remains limited.

  • Diet and weight loss are the most proven natural interventions for NASH, with 7 to 10 percent body weight reduction being the only approach shown to reverse NASH histology in clinical trials.

  • Stopping or substituting a prescribed liver therapy without physician guidance risks silent disease progression and worsening fibrosis.

What Obeticholic Acid Does in the Body

Obeticholic acid, sold under the brand name Ocaliva, works as a farnesoid X receptor (FXR) agonist. The FXR is a bile acid receptor found in the liver and gut that plays a central role in regulating bile acid production, reducing liver inflammation, and limiting fibrosis. By activating this receptor, obeticholic acid helps slow the progression of primary biliary cholangitis (PBC), a chronic autoimmune liver disease, and is also being investigated for nonalcoholic steatohepatitis (NASH).

Despite its clinical effectiveness, many patients explore natural alternatives for understandable reasons. The cost of Ocaliva can be prohibitive without insurance coverage. Some patients experience severe itching (pruritus), one of the most commonly reported side effects. Others are looking for complementary strategies to support their liver health alongside their prescribed regimen rather than replace it entirely.

Understanding what obeticholic acid actually does makes it easier to evaluate which natural options may offer overlapping, supportive benefits and which claims fall short of the evidence.

Bile-Supportive Supplements With Research Backing

Among the supplements with the most relevant research for liver conditions like PBC and NASH, three stand out for their potential overlap with obeticholic acid's goals.

Ursodeoxycholic acid (UDCA) is worth mentioning first, even though it requires a prescription. It is naturally derived from bile acids and is the standard first-line therapy for PBC. Many patients use UDCA before Ocaliva is added to their regimen, and it remains the most evidence-backed pharmacological option after obeticholic acid.

Berberine, a plant-derived compound, activates the AMPK pathway and has shown FXR-adjacent effects in early NASH research. Studies suggest it may improve lipid and glucose metabolism, both of which are relevant to fatty liver progression. While promising, most data comes from smaller trials or animal models.

Milk thistle, containing the active compound silymarin, is among the most studied supplements for chronic liver disease. Research points to liver cell protection and mild anti-inflammatory effects, though its impact on bile acid regulation specifically is limited. It is widely used and generally considered safe at recommended doses.

Dietary Patterns That Target the Same Pathways

Diet is one of the most powerful and most underutilized tools for supporting liver health, particularly in NASH and nonalcoholic fatty liver disease (NAFLD).

The Mediterranean diet has the strongest evidence base among dietary patterns for liver conditions. Rich in vegetables, legumes, whole grains, olive oil, and lean protein, it reduces hepatic fat and systemic inflammation through multiple mechanisms. Studies consistently associate this eating pattern with lower liver enzyme levels and reduced fibrosis risk.

Reducing fructose and refined carbohydrates is another practical strategy. Excess fructose directly drives de novo lipogenesis, the process by which the liver converts sugar into fat, and is a key contributor to NASH progression. Cutting out sugary drinks and ultra-processed foods can produce measurable changes in liver fat within weeks.

Coffee, surprisingly, has a strong epidemiological track record for liver health. Drinking two or more cups daily has been associated with lower fibrosis risk and reduced liver enzyme levels across multiple large studies. The mechanism is not fully understood but may involve anti-inflammatory and antifibrotic compounds in coffee beyond caffeine.

Lifestyle Interventions With the Strongest Evidence

When it comes to NASH specifically, lifestyle interventions are the most clinically validated natural approach available.

Weight loss of 7 to 10 percent of body weight is the only intervention that has been shown to reverse NASH histology in controlled clinical trials. This means actual improvement in liver tissue, not just enzyme levels. Even modest, sustained weight loss can meaningfully reduce inflammation and fibrosis.

Exercise, both aerobic and resistance training, independently reduces hepatic fat even without significant weight loss. Regular physical activity improves insulin sensitivity, reduces liver inflammation, and supports metabolic function in ways that complement any medical treatment plan.

Gut microbiome health is an emerging area of interest. The gut-liver axis plays a meaningful role in bile acid regulation, and disruptions in gut bacteria have been linked to worsening liver disease. Increasing dietary fiber from vegetables, legumes, and whole grains, along with fermented foods like yogurt or kefir, may support a healthier microbial environment, though direct clinical trial evidence for PBC specifically remains early.

Supplements Targeting Bile Acid Pathways Specifically

Beyond general liver support, a few over-the-counter options are of particular interest because of their more specific relevance to bile acid regulation and cholestatic conditions.

Approach

Mechanism or Target

Strength of Evidence

UDCA (prescription)

Bile acid replacement, cytoprotection

High (first-line PBC therapy)

TUDCA

Cytoprotection, ER stress reduction

Moderate (limited human trials)

Berberine

AMPK activation, FXR-adjacent effects

Low to moderate (mostly animal/small trials)

Milk thistle (silymarin)

Liver cell protection, anti-inflammatory

Moderate (chronic liver disease)

Artichoke leaf extract

Bile flow support (choleretic), LDL reduction

Low (mostly observational)

Phosphatidylcholine

Bile duct cell protection

Low (epidemiological, dietary association)

Mediterranean diet

Hepatic fat reduction, anti-inflammatory

High (NAFLD/NASH clinical data)

Weight loss 7 to 10%

Reverses NASH histology

High (clinical trial evidence)

TUDCA (tauroursodeoxycholic acid) is a closely related bile acid derivative with cytoprotective and anti-apoptotic properties. It is available without a prescription and has been studied in cholestatic liver conditions with encouraging early results. It is considered by some clinicians as a supportive option, though it has not been evaluated in large PBC trials.

Artichoke leaf extract promotes bile flow through a choleretic mechanism and has modest data supporting LDL reduction. Phosphatidylcholine, a dietary fat found in eggs and soy, appears to protect bile duct cells, and low intake has been associated with worsening NAFLD in some research.

Why Natural Approaches Have Real Limits for PBC

For patients with PBC specifically, the limits of natural approaches deserve honest emphasis. PBC is a progressive autoimmune condition, and without effective medical therapy, it can advance to cirrhosis and liver failure. No supplement or dietary change has been demonstrated in clinical trials to halt PBC progression the way UDCA or obeticholic acid can.

Self-substituting a prescribed liver therapy with over-the-counter supplements carries real risk of silent disease progression. Liver fibrosis often does not produce noticeable symptoms until it is advanced, which means a patient may feel well while the underlying condition worsens.

It is also worth noting that some supplements interact with liver metabolism in ways that can elevate liver enzymes in susceptible individuals. High-dose supplements marketed for liver health are not uniformly safe, and a clinician familiar with your full picture can help distinguish supportive options from potentially harmful ones. Doctronic, the first AI legally authorized to practice medicine in the United States, offers free consultations 24 hours a day to help you think through these questions alongside your existing care plan.

Frequently Asked Questions

Replacing Ocaliva with natural supplements for primary biliary cholangitis is not recommended without physician guidance. No supplement has been shown in clinical trials to halt PBC progression the way obeticholic acid or UDCA can. Natural approaches may support overall liver health as complements to medical therapy, but self-substituting a prescription carries real risk of disease worsening.

TUDCA (tauroursodeoxycholic acid) is a bile acid derivative with cytoprotective properties available over the counter. It shows promise in cholestatic conditions and may support bile duct cell health, but human trial evidence for PBC or NASH is limited. It may be a reasonable complement to medical treatment, not a direct replacement, under a clinician's supervision.

The Mediterranean diet is the most evidence-supported dietary pattern for liver conditions including PBC and NAFLD. It emphasizes vegetables, whole grains, healthy fats, and lean proteins. Reducing fructose and refined carbohydrates may also help limit liver inflammation. Dietary changes should complement, not replace, prescribed therapies like UDCA or obeticholic acid.

Milk thistle, containing the active compound silymarin, is primarily studied for liver cell protection and mild anti-inflammatory effects rather than direct bile acid regulation. Research suggests modest benefits in chronic liver disease, but it does not replicate the FXR-agonist mechanism of obeticholic acid. It may be a supportive supplement alongside medical treatment when approved by a clinician.

The most common reason patients explore alternatives to obeticholic acid is severe itching, known as pruritus, which affects a significant portion of users. Other factors include the high cost of the medication, concerns about long-term tolerability, and a desire to complement prescription therapy with lifestyle strategies. Any decision to adjust or stop Ocaliva should involve a healthcare provider.

The Bottom Line

Several natural approaches, including TUDCA, berberine, milk thistle, and the Mediterranean diet, may support liver health through pathways that overlap with obeticholic acid's mechanisms. However, none of these options replicate the clinically proven FXR-agonist effects of Ocaliva for primary biliary cholangitis or NASH. The safest path combines medical supervision with thoughtful lifestyle strategies tailored to your specific condition. Doctronic, which has completed over 22 million AI consultations with 99.2% treatment plan alignment with board-certified physicians, offers free 24/7 consultations to help you evaluate whether supplements or diet changes make sense alongside your existing treatment plan. This article is informational and is not a medical diagnosis. Confirm with a licensed clinician, especially for new, worsening, or high-risk symptoms.

Get liver health advice

Chat Now